第 1 到 45 筆結果,共 45 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | Assessment of Narrow-Band Imaging Algorithm for Video Capsule Endoscopy Based on Decorrelated Color Space for Esophageal Cancer: Part II, Detection and Classification of Esophageal Cancer | YU-JEN FANG ; Huang, Chien-Wei; Karmakar, Riya; Mukundan, Arvind; Tsao, Yu-Ming; Yang, Kai-Yao; Wang, Hsiang-Chen | Cancers | |||
2 | 2024 | Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis | TZU-CHAN HONG ; El-Omar, Emad M; YU-TING KUO ; Wu, Jeng-Yih; MEI-JYH CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Leow, Alex Hwong Ruey; Lu, Hong; JAW-TOWN LIN ; YU-KANG TU ; Yamaoka, Yoshio; MING-SHIANG WU ; JYH-MING LIOU | The lancet. Gastroenterology & hepatology | 2 | ||
3 | 2024 | Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation | Tsai, Ying-Nan; Wu, Jia-Ling; Tseng, Cheng-Hao; Chen, Tzu-Haw; Wu, Yi-Ling; CHIEH-CHANG CHEN ; YU-JEN FANG ; Yang, Tzeng-Huey; Nguyen, Mindie H; JAW-TOWN LIN ; Hsu, Yao-Chun | Clinical and molecular hepatology | |||
4 | 2023 | Assessment of Narrow Band Imaging Algorithm for Video Capsule Endoscopy Based on Decorrelated Color Space for Esophageal Cancer | Yang, Kai-Yao; YU-JEN FANG ; Karmakar, Riya; Mukundan, Arvind; Tsao, Yu-Ming; Huang, Chien-Wei; Wang, Hsiang-Chen | Cancers | 2 | 1 | |
5 | 2023 | Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials | MEI-JYH CHEN ; Chen, Po-Yueh; YU-JEN FANG ; Bair, Ming-Jong; CHIEH-CHANG CHEN ; CHIEN-CHUAN CHEN ; Yang, Tsung-Hua; Lee, Ji-Yuh; Yu, Chien-Chun; Kuo, Chia-Chi; Chiu, Min-Chin; Chou, Chu-Kuang; Chen, Chi-Yi; Hu, Wen-Hao; Tsai, Min-Horn; Hsu, Yao-Chun; CHIA-TUNG SHUN ; Luo, Jiing-Chyuan; JAW-TOWN LIN ; El-Omar, Emad M; MING-SHIANG WU ; JYH-MING LIOU | The lancet. Gastroenterology & hepatology | 9 | 5 | |
6 | 2023 | Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection | CHEN-HUA LIU ; YU-JEN FANG ; CHUN-JEN LIU ; TUNG-HUNG SU ; SHANG-CHIN HUANG ; TAI-CHUNG TSENG ; Wu, Jo-Hsuan; PEI-JER CHEN ; JIA-HORNG KAO | Journal of clinical medicine | 0 | 0 | |
7 | 2023 | Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial | JYH-MING LIOU ; Jiang, Xiao-Tao; CHIEH-CHANG CHEN ; Luo, Jiing-Chyuan; Bair, Ming-Jong; Chen, Po-Yueh; Chou, Chu-Kuang; YU-JEN FANG ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Lee, Ji-Yuh; Yang, Tsung-Hua; Yu, Chien-Chun; Kuo, Chia-Chi; Chiu, Min-Chin; Chen, Chi-Yi; CHIA-TUNG SHUN ; Hu, Wen-Hao; Tsai, Min-Horn; Hsu, Yao-Chun; Tseng, Cheng-Hao; Chang, Chi-Yang; JAW-TOWN LIN ; El-Omar, Emad M; MING-SHIANG WU ; Wu, Chun-Ying; Lee, Yi-Chia; PING-HUEI TSENG ; Wu, Jeng-Yih; Tai, Chi-Ming; Lee, Ching-Tai; Wang, Wen-Lun | The lancet. Gastroenterology & hepatology | 11 | 6 | |
8 | 2023 | Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan | CHEN-HUA LIU ; Peng, Cheng-Yuan; CHUN-JEN LIU ; Chen, Chi-Yi; Lo, Ching-Chu; Tseng, Kuo-Chih; Su, Pei-Yuan; Kao, Wei-Yu; Tsai, Ming-Chang; Tung, Hung-Da; Cheng, Hao-Tsai; Lee, Fu-Jen; Huang, Chia-Sheng; Huang, Ke-Jhang; Shih, Yu-Lueng; Yang, Sheng-Shun; Wu, Jo-Hsuan; Lai, Hsueh-Chou; YU-JEN FANG ; Chen, Po-Yueh; Hwang, Jow-Jyh; Tseng, Chi-Wei; Su, Wei-Wen; Chang, Chun-Chao; Lee, Pei-Lun; Chen, Jyh-Jou; Chang, Chi-Yang; Hsieh, Tsai-Yuan; Chang, Chung-Hsin; Huang, Yi-Jie; JIA-HORNG KAO | Hepatology international | 5 | 4 | |
9 | 2022 | Randomized controlled trial of early endoscopy for upper gastrointestinal bleeding in acute coronary syndrome patients | Chung, Chen-Shuan; CHIEH-CHANG CHEN ; Chen, Kuan-Chih; YU-JEN FANG ; WEN-FENG HSU ; YEN-NIEN CHEN ; Tseng, Wei-Chuang; Lin, Cheng-Kuan; Lee, Tzong-Hsi; HSIU-PO WANG ; YEN-WEN WU | Scientific reports | 2 | 1 | |
10 | 2022 | Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis | MEI-JYH CHEN ; Bair, Ming-Jong; Chen, Po-Yueh; Lee, Ji-Yuh; Yang, Tsung-Hua; YU-JEN FANG ; CHIEH-CHANG CHEN ; Chang, An-Ti; Hsiao, Wang-De; Yu, Jian-Jyun; Kuo, Chia-Chi; Chiu, Min-Chin; Kun-Pei Lin ; Tsai, Min-Horn; Hsu, Yao-Chun; Chou, Chu-Kuang; Chen, Chi-Yi; JAW-TOWN LIN ; YI-CHIA LEE ; MING-SHIANG WU ; JYH-MING LIOU ; forthe Taiwan Gastrointestinal Disease; Helicobacter Consortium | Helicobacter | 7 | 6 | |
11 | 2022 | Identification of Early Esophageal Cancer by Semantic Segmentation | YU-JEN FANG ; Mukundan, Arvind; Tsao, Yu-Ming; Huang, Chien-Wei; Wang, Hsiang-Chen | Journal of personalized medicine | 26 | 18 | |
12 | 2021 | Community-Based Gastric Cancer Screening Coupled With a National Colorectal Cancer Screening Program: Baseline Results | YI-CHIA LEE ; TSUNG-HSIEN CHIANG ; HAN-MO CHIU ; MING-SHIANG WU ; Yeh, Yen-Po; Hsiu-Hsi Chen, Tony; Li-Sheng Chen S.; Ming-Fang Yen A.; Ching-Yuan Fann J.; Yueh-Hsia Chiu S.; Hsu C.-Y.; Chuang S.-L.; Chou K.-C.; Su W.-W.; Chen S.-T.; Liao C.-S.; Lin Y.-M.; Chang H.-C.; Hu T.-H.; YU-JEN FANG ; CHANG-CHUAN CHAN ; Collaborators of the Taiwan Community-Based Integrated Screening Group | Gastroenterology | 7 | 7 | |
13 | 2021 | The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota—a double-blind, placebo-controlled, randomized trial | MEI-JYH CHEN ; CHIEH-CHANG CHEN ; Huang Y.-C.; Tseng C.-C.; Hsu J.-T.; Lin Y.-F.; YU-JEN FANG ; MING-SHIANG WU ; JYH-MING LIOU ; for the Taiwan Gastrointestinal Disease, Helicobacter Consortium | Helicobacter | 16 | 14 | |
14 | 2021 | Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan | CHEN-HUA LIU ; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; CHUN-JEN LIU ; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG ; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; CHIEN-CHING HUNG ; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T. Y.; JIA-HORNG KAO | Hepatology International | 14 | 14 | |
15 | 2021 | Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis | CHEN-HUA LIU ; Chen C.-Y.; Su W.-W.; CHUN-JEN LIU ; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG ; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; JIA-HORNG KAO | Clinical and Molecular Hepatology | 8 | 8 | |
16 | 2020 | Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles | CHIEH-CHANG CHEN ; WEI-KAI WU ; Chang, Chih-Min; Panyod, Suraphan; TZU-PIN LU ; JYH-MING LIOU ; YU-JEN FANG ; ERIC YAO-YU CHUANG ; MING-SHIANG WU | Journal of the Formosan Medical Association = Taiwan yi zhi | 18 | 13 | |
17 | 2020 | Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan | MEI-JYH CHEN ; YU-JEN FANG ; MING-SHIANG WU ; CHIEH-CHANG CHEN ; YEN-NIEN CHEN ; Yu C.-C.; Kuo C.-C.; Chiu M.-C.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen H.-H.; Bair M.-J.; JYH-MING LIOU ; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Gastroenterology and Hepatology (Australia) | 9 | 7 | |
18 | 2020 | Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan | YU-JEN FANG ; MEI-JYH CHEN ; CHIEH-CHANG CHEN ; Lee J.-Y.; Yang T.-H.; Yu C.-C.; Chiu M.-C.; Kuo C.-C.; Weng Y.-J.; Bair M.-J.; MING-SHIANG WU ; Luo J.-C.; JYH-MING LIOU | Journal of the Formosan Medical Association | 13 | 10 | |
19 | 2020 | Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis | CHEN-HUA LIU ; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; TUNG-HUNG SU ; CHUN-JEN LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Scientific Reports | 8 | 6 | |
20 | 2020 | Microelimination of chronic hepatitis C by universal screening plus direct-acting antivirals for incarcerated persons in Taiwan | Yang T.-H.; YU-JEN FANG ; SHIH-JER HSU ; Lee J.-Y.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; CHIEN-HUNG CHEN | Open Forum Infectious Diseases | 24 | 25 | |
21 | 2020 | Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment | CHEN-HUA LIU ; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; CHUN-JEN LIU ; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG ; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; JIA-HORNG KAO | Gut | 26 | 27 | |
22 | 2020 | Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial | CHIEH-CHANG CHEN ; Luo J.-C.; YU-JEN FANG ; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; MEI-JYH CHEN ; CHIA-TUNG SHUN ; Liu T.-Y.; YI-CHIA LEE ; Liou§ J.-M.; MING-SHIANG WU ; and for the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Therapeutic Advances in Gastroenterology | 5 | 6 | |
23 | 2019 | Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis | CHEN-HUA LIU ; Shih Y.-L; Yang S.-S; Lin C.-L; YU-JEN FANG ; Cheng P.-N; Chen C.-Y; Peng C.-Y; Hsieh T.-Y; Chiu Y.-C; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 7 | 7 | |
24 | 2019 | Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang, C.-M.; YU-JEN FANG ; Bair, M.-J.; Chen, P.-Y.; Chang, C.-Y.; Hsu, Y.-C.; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Lee, J.-Y.; Yang, T.-H.; Luo, J.-C.; Chen, C.-Y.; WEN-FENG HSU ; YEN-NIEN CHEN ; Wu, J.-Y.; Lin, J.-T.; TZU-PIN LU ; Chuang, E.Y.; El-Omar, E.M.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease; ERIC YAO-YU CHUANG | The Lancet Infectious Diseases | 125 | 111 | |
25 | 2019 | Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C | SHIH-JER HSU ; Chiu M.-C.; YU-JEN FANG ; Yang T.-H.; Yu J.-J.; CHIEH-CHANG CHEN ; Kuo C.-C.; Lee J.-Y.; CHIEN-HUNG CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association | 19 | 16 | |
26 | 2018 | Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection | Liou, Jyh-Ming; Chen, Po-Yueh; Luo, Jiing-Chyuan; Lee, Ji-Yuh; CHIEH-CHANG CHEN ; YU-JEN FANG ; Yang, Tsung-Hua; Chang, Chi-Yang; Bair, Ming-Jong; MEI-JYH CHEN ; Hsu, Yao-Chun; WEN-FENG HSU ; Chang, Chun-Chao; JAW-TOWN LIN ; CHIA-TUNG SHUN ; El-Omar, Emad M.; MING-SHIANG WU ; Liou, Jyh-Ming; YI-CHIA LEE ; Lin, Jaw-Town; Wu, Chun-Ying; Wu, Jeng-Yih; Lin, Chun-Hung; Fang, Yu-Ren; Luo, Jiing-Chyuan; TSU-YAO CHENG ; PING-HUEI TSENG ; HAN-MO CHIU ; Chang, Chun-Chao; Yu, Chien-Chun; Chiu, Min-Chin; YEN-NIEN CHEN ; Hu, Wen-Hao; Chou, Chu-Kuang; Tai, Chi-Ming; Lee, Ching-Tai; Wang, Wen-Lun; Chang, Wen-Shiung; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Gastroenterology | 61 | 50 | |
27 | 2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; MEI-JYH CHEN ; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Lin J.-T.; CHIA-TUNG SHUN ; Twu G.; YI-CHIA LEE ; Bair M.-J.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 18 | 15 | |
28 | 2018 | Systematic review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection | MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; YEN-NIEN CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lin J.-T.; MING-SHIANG WU ; JYH-MING LIOU ; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium | American Journal of Gastroenterology | 30 | 25 | |
29 | 2017 | Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials | MEI-JYH CHEN ; MING-SHIANG WU ; CHIEN-CHUAN CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; WEN-FENG HSU ; Luo J.-C.; Lin J.-T.; JYH-MING LIOU ; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 21 | 20 | |
30 | 2017 | Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; YU-JEN FANG ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Open Forum Infectious Diseases | 42 | 39 | |
31 | 2016 | Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial | JYH-MING LIOU ; YU-JEN FANG ; CHIEH-CHANG CHEN ; Bair, Ming-Jong; Chang, Chi-Yang; YI-CHIA LEE ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Tseng, Cheng-Hao; Hsu, Yao-Chun; Lee, Ji-Yuh; Yang, Tsung-Hua; Luo, Jiing-Chyuan; Chang, Chun-Chao; Chen, Chi-Yi; Chen, Po-Yueh; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hu, Wen-Hao; YEN-NIEN CHEN ; Sheu, Bor-Shyang; Lin, Jaw-Town; Wu, Jeng-Yih; El-Omar, Emad M; MING-SHIANG WU | Lancet (London, England) | 120 | 112 | |
32 | 2016 | Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial | JYH-MING LIOU ; Bair M.-J.; CHIEH-CHANG CHEN ; YI-CHIA LEE ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Tseng C.-H.; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; CHIA-TUNG SHUN ; WEN-FENG HSU ; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU | American Journal of Gastroenterology | 40 | 38 | |
33 | 2016 | Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang C.-Y.; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; CHIA-TUNG SHUN ; Lin J.-T.; YI-CHIA LEE ; MING-SHIANG WU ; the Taiwan Gastrointestinal Disease and Helicobacter Consortium; Helicobacter Consortium | Gut | 62 | 59 | |
34 | 2016 | Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients | Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; MING-SHIANG WU ; JIA-HORNG KAO ; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; CHIEH-CHANG CHEN ; YU-JEN FANG ; Hung H.-W.; Wu C.-Y.; Lin J.-T. | Clinical Gastroenterology and Hepatology | 40 | 33 | |
35 | 2015 | Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria | YU-JEN FANG ; JYH-MING LIOU ; CHIEH-CHANG CHEN ; Lee J.-Y.; Hsu Y.-C.; MEI-JYH CHEN ; PING-HUEI TSENG ; CHIEN-CHUAN CHEN ; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; HSIU-PO WANG ; Luo J.-C.; Lin J.-T.; CHIA-TUNG SHUN ; MING-SHIANG WU | Gut | 66 | 51 | |
36 | 2015 | The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study | JYH-MING LIOU ; Chang C.-Y.; MEI-JYH CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; HSIU-PO WANG ; Sheu B.-S.; Lin J.-T.; Bair M.-J.; MING-SHIANG WU ; Tai C.-M.; Lee C.-T.; Wang W.-L.; YI-CHIA LEE ; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | PLoS ONE | 65 | 63 | |
37 | 2013 | Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; Chang, Chi-Yang; YU-JEN FANG ; Lee, Ji-Yuh; SHIH-JER HSU ; Luo, Jiing-Chyuan; Chang, Wen-Hsiung; Hsu, Yao-Chun; Tseng, Cheng-Hao; PING-HUEI TSENG ; HSIU-PO WANG ; Yang, Ueng-Cheng; CHIA-TUNG SHUN ; Lin, Jaw-Town; YI-CHIA LEE ; MING-SHIANG WU | LANCET | 219 | 196 | |
38 | 2013 | Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; Chang C.-Y.; MEI-JYH CHEN ; YU-JEN FANG ; Lee J.-Y.; CHIEN-CHUAN CHEN ; SHIH-JER HSU ; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG ; Chang L.; Chang W.-H.; HSIU-PO WANG ; CHIA-TUNG SHUN ; Wu J.-Y.; YI-CHIA LEE ; Lin J.-T.; MING-SHIANG WU ; Lin C.-H.; LU-PING CHOW ; TSU-YAO CHENG ; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; CHIH-HSIEN WANG ; Kuo S.-H.; Wu C.-Y. | Journal of Antimicrobial Chemotherapy | 76 | 73 | |
39 | 2012 | Suggested cutoff tumor size for management of small EUS-suspected gastric gastrointestinal stromal tumors | YU-JEN FANG ; TSU-YAO CHENG ; Sun M.-S.; Yang C.-S.; Chen J.-H.; WEI-CHIH LIAO ; HSIU-PO WANG | Journal of the Formosan Medical Association | 30 | 26 | |
40 | 2012 | Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma | SHIH-HUNG YANG ; Lin L.-W.; YU-JEN FANG ; ANN-LII CHENG ; SUNG-HSIN KUO | Annals of Hematology | 6 | 2 | |
41 | 2012 | Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers | CHIEN-CHUAN CHEN ; Lee J.-Y.; YU-JEN FANG ; SHIH-JER HSU ; MING-LUN HAN ; PING-HUEI TSENG ; JYH-MING LIOU ; Hu F.-C.; Lin T.-L.; MING-SHIANG WU ; HSIU-PO WANG ; Lin J.-T. | Alimentary Pharmacology and Therapeutics | 30 | 27 | |
42 | 2012 | Computer-generated surface and tone enhancements to distinguish neoplastic from non-neoplastic colon polyps less than 1 cm in diameter | MING-LUN HAN ; YI-CHIA LEE ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lee J.-Y.; Lin T.-L.; Lin L.-W.; PING-HUEI TSENG ; MING-SHIANG WU ; HSIU-PO WANG | International Journal of Colorectal Disease | 4 | 3 | |
43 | 2011 | Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial | JYH-MING LIOU ; CHIEH-CHANG CHEN ; MEI-JYH CHEN ; Chang C.-Y.; YU-JEN FANG ; Lee J.-Y.; WANG-HUEI SHENG ; HSIU-PO WANG ; MING-SHIANG WU ; Lin J.-T. | Journal of Antimicrobial Chemotherapy | 40 | 40 | |
44 | 2009 | Barium appendicitis | YU-JEN FANG ; HSIU-PO WANG ; CHENG-MAW HO ; KAO-LANG LIU | Surgery | 10 | 12 | |
45 | 2008 | A rare diagnosis of right upper quadrant abdominal pain | Chung C.-S.; HSIU-PO WANG ; YU-JEN FANG ; REY-HENG HU ; Hsiao J.-K.; Chen C.-G.H. | Gut | 0 | 0 |